Evidence map›Paper›PMID 40475618›Full record

ArticlebioRxiv : the preprint server for biology2025

RAC1 Regulates Shh-Medulloblastoma Growth via GLI-Mediated Transcription.

Nitish Jangde, Mi Hye Lee, Luz Ruiz, Isabelle Egan, Anna M Jermakowicz, Daniel Wynn, Erik Goka, Marc Lippman, David J Robbins, Nagi G Ayad

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Isabelle Egan
Anna M Jermakowicz
Daniel Wynn
Erik Goka
David J Robbins

Funding

Epigenetic pathways and cell cycle exitR01NS118023 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI AYAD, NAGI G · 2020 to 2024
$1.8M
Rac1 Inhibition for the treatment of medulloblastomaR21NS135506 · NINDS · GEORGETOWN UNIVERSITY · PI AYAD, NAGI G · 2024 to 2025
$429k
NINDS NIH HHS R01 NS118023NINDS NIH HHS R21 NS135506
6 · The paper itself

Abstract

Medulloblastoma (MB) is the most common malignant primary pediatric brain tumor. Current therapies are ineffective for targeting proliferation, leptomeningeal migration, and metastasis of MB cancer cells to visceral organs and therefore, novel treatments are needed. The small GTPase, RAC1, has emerged as an important regulator of actin cytoskeletal dynamics, proliferation, and migration in several cancers. However, it has not been characterized in MB and no clinical drug candidates have been described for RAC1 in MB. Here we demonstrate that RAC1 levels are higher in MB tissue relative to normal cerebellum. Further, RAC1 depletion significantly reduces proliferation and migration of Shh-MB cells Graphical abstract:

Identifiers

PMID40475618
PMCPMC12139870

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.